Medtech company Bone Index has announced the successful close of its latest financing round and a new strategic partnership with Lynx Financial. This collaboration is set to enhance Bone Index’s distribution and service capabilities across North America and the Asia Pacific regions, allowing the company to meet the increasing demand for its bone health diagnostic solutions in these key markets. The funding,…
Alife Health, a fertility technology company focused on modernizing in vitro fertilization (IVF) through AI, has revealed promising findings from a study that explores the role of artificial intelligence in optimizing ovarian stimulation during IVF treatment. The study, titled “Optimizing Oocyte Yield Utilizing a Machine Learning Model for Dose and Trigger Decisions: A Multi-Center, Prospective Study,” was conducted by a team of…
GE HealthCare has announced a new collaboration with the University of California San Diego School of Medicine to enhance imaging techniques for diagnosing and managing female pelvic diseases, such as endometriosis and ovarian cancer. This partnership, which will be conducted through the Center for Translational Imaging and Precision Medicine (CTIPM) at UC San Diego, aims to develop advanced magnetic resonance imaging (MRI)…
Femtech Canada has officially submitted a request to the Canadian federal government, advocating for a $100 million investment to accelerate women’s health and femtech innovation across the country. This funding would support initiatives aimed at addressing longstanding gaps in women’s healthcare and driving advancements in the rapidly growing femtech sector. The proposal is part of Femtech Canada’s push to have women’s health…
Motherbeing, an Egypt-based femtech company, has launched a new mobile app called Daleela, designed to use AI technology to provide Arab women with secure, private access to information and personalized support related to their sexual and reproductive health. Available on both iOS and Android, Daleela offers a platform where women can engage with an AI assistant to receive tailored advice on topics…
The new AI-powered Feeling Great app has raised $8 million in seed funding to bring innovative mental health care solutions to users worldwide. This funding round was co-led by Learn Capital and TitleTownTech, with additional participation from Lux Ventures, WaveMaker Three-Sixty Health, Pacific Health Ventures, and Treble Capital. Developed by Dr. David D. Burns, a renowned psychiatrist and best-selling author, along with…
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on novel treatments for severe ischemic diseases, has announced the initiation of a Phase 2 trial for their preeclampsia treatment, DM199. This announcement came alongside their second quarter 2024 financial results and business update. Preeclampsia (PE) is a serious pregnancy complication characterized by high blood pressure and damage to organ systems, often affecting the kidneys…
Johnson & Johnson has announced significant findings from their Phase 2 UNITY study of nipocalimab for the treatment of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN). The results, published in The New England Journal of Medicine, indicate that nipocalimab can delay or prevent severe fetal anemia and improve birth outcomes. HDFN occurs…
